$HUGE News Article - FSD Pharma announces Interim Results from First-in-Human Clinical Trial of Lucid-MS (Lucid-21-302) for Multiple Sclerosis; The Report Shows Compound to be Safe and Well Tolerated
https://marketwirenews.com/news-releases/fsd-...63530.html